Mary Kay Fenton serves as Executive at ACHILLION PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Mary Kay Fenton has executed 17 insider transactions totaling $932.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 3, 2023 involved selling 12,946 shares valued at $39.9K.
Mary Kay Fenton currently holds 68,054 shares of ACHILLION PHARMACEUTICALS INC (ACHN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mary Kay Fenton has been a net seller of ACHN stock. They have purchased $10.3K and sold $922.5K worth of shares.
Mary Kay Fenton's most recent insider trade was on Jul 3, 2023, when they sold 12,946 shares at $3.08 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 31, 2021 | TALS | $13.0K | Award | 1,000 | $13.00 | Discretionary |
| Dec 5, 2016 | ACHN | $10.3K | Purchase | 2,500 | $4.11 | Discretionary |
| Dec 28, 2015 | ACHN | $438.5K | Sale | 43,500 | $10.08 | Discretionary |
| Dec 28, 2015 | ACHN | $45.7K | Option Exercise | 43,500 | $1.05 | Discretionary |
| Jan 23, 2015 | ACHN | $210.0K | Sale | 13,125 | $16.00 | Discretionary |
| Jan 23, 2015 | ACHN | $52.5K | Option Exercise | 13,125 | $4.00 | Discretionary |
| Jan 10, 2012 | ACHN | $127.5K | Sale | 10,625 | $12.00 | Discretionary |
| Jan 10, 2012 | ACHN | $17.0K | Option Exercise | 10,625 | $1.60 | Discretionary |
| Jan 9, 2012 | ACHN | $40.9K | Sale | 4,375 | $9.34 | Discretionary |
| Apr 6, 2011 | ACHN | $1.0K | Sale | 139 | $7.50 | Discretionary |
| Apr 5, 2011 | ACHN | $30.8K | Sale | 4,111 | $7.50 | Discretionary |
| Mar 30, 2011 | ACHN | $30.0K | Sale | 4,000 | $7.50 | Discretionary |
| Jan 13, 2011 | ACHN | $43.8K | Sale | 8,750 | $5.00 | Discretionary |
| Sep 5, 2008 | ACHN | $5.0K | Option Exercise | 3,125 | $1.60 | Discretionary |
| Dec 18, 2006 | ACHN | $2.0K | Option Exercise | 1,250 | $1.60 | Discretionary |